Abstract:Cytoplasmic export of the RNA-binding protein HuR, a process that critically regulates its function, was recently shown to be inhibited by the AMP-activated protein kinase ( AMPK). In the present investigation, treatment of human fibroblasts with AMPK activators such as 5-amino-imidazole-4-carboxamide riboside, antimycin A, and sodium azide inhibited cell growth and lowered the expression of proliferative genes. As anticipated, AMPK activation also decreased both the cytoplasmic HuR levels and the association of HuR with target radiolabeled transcripts encoding such proliferative genes. HuR function was previously shown to be implicated in the maintenance of a "young cell" phenotype in models of replicative cellular senescence. We therefore postulated that AMPK activation in human fibroblasts might contribute to the implementation of the senescence phenotype through mechanisms that included a reduction in HuR cytoplasmic presence. Indeed, AMP: ATP ratios were 2 -3-fold higher in senescent fibroblasts compared with young fibroblasts. Accordingly, in vitro senescence was accompanied by a marked elevation in AMPK activity. Evidence that increased AMPK activity directly contributed to the implementation of the senescent phenotype was obtained through two experimental approaches. First, use of AMPK activators triggered senescence characteristics in fibroblasts, such as the acquisition of senescence-associated beta-galactosidase (beta-gal) activity and increased p16(INK4a) expression. Second, infection of cells with an adenoviral vector that expresses active AMPK increased senescence-associated beta-gal activity, whereas infection with an adenovirus that expresses dominant-negative AMPK decreased senescence-associated beta-gal activity. Together, our results indicate that AMPK activation can cause premature fibroblast senescence through mechanisms that likely involve reduced HuR function.

Modulation of the expression of p16INK4a and p14ARF by hnRNP A1 and A2 RNA binding proteins: Implications for cellular senescence

P21waf1/cip1 Plays a Critical Role in Modulating Senescence Through Changes of DNA Methylation

Increased Stability of the P16 Mrna with Replicative Senescence

The Tumor Suppressor P33ing1b Upregulates P16ink4a Expression and Induces Cellular Senescence

Sp1 Is Essential For P16(Ink4a) Expression In Human Diploid Fibroblasts During Senescence

Regulation of Cellular Senescence and p16INK4a Expression by Id1 and E47 Proteins in Human Diploid Fibroblast

Characterization of Regulatory Elements on the Promoter Region of P16(ink4a) That Contribute to Overexpression of P16 in Senescent Fibroblasts.

Hnrnp A1 Antagonizes Cellular Senescence and Senescence‐associated Secretory Phenotype Via Regulation of SIRT1 Mrna Stability

FOXA1 mediates p16(INK4a) activation during cellular senescence.

Posttranscriptional Induction of P21waf1 Mediated by Ectopic P16ink4 in Human Diploid Fibroblast

Prevalent Intron Retention Fine‐tunes Gene Expression and Contributes to Cellular Senescence

FOXA1 Mediates P16ink4a Activation During Cellular Senescence

Cell Senescence and Transcriptional Regulation of P16ink4a

Senescence Delay and Repression of P16(Ink4a) by Lsh Via Recruitment of Histone Deacetylases in Human Diploid Fibroblasts

Enhancer of Zeste Homolog 2 Depletion Induces Cellular Senescence Via Histone Demethylation along the Ink4/Arf Locus

The P53/mirnas/ccna2 Pathway Serves As a Novel Regulator of Cellular Senescence: Complement of the Canonical P53/p21 Pathway

Cellular senescence is regulated by p21Waf1/Cip1 methylation

Increased Amp : Atp Ratio And Amp-Activated Protein Kinase Activity During Cellular Senescence Linked To Reduced Hur Function

Alternative polyadenylation dependent function of splicing factor SRSF3 contributes to cellular senescence.

Cdkn1a transcript variant 2 is a marker of aging and cellular senescence

YY1 Restrained Cell Senescence Through Repressing the Transcription of P16